Folate and methotrexate interactions in the rat kidney

Area of Science:

• Nephrology
• Pharmacology
• Biochemistry

Background:

• Understanding renal handling of folate analogs is crucial for optimizing chemotherapy.
• Methotrexate (MTX) and folates share renal transport mechanisms, but their interactions are not fully elucidated.

Purpose of the Study:

• To investigate the mechanisms governing renal retention and urinary excretion of methotrexate and folates in rats.
• To characterize the specific systems involved in methotrexate's renal disposition.

Main Methods:

• Intravenous administration of radiolabeled folic acid and methotrexate in rats.
• Inhibition studies using varying concentrations of folic acid, 5-methyltetrahydrofolate, and methotrexate.
• Analysis of folate binder affinities in solubilized kidney extracts.
• Measurement of endogenous folate urinary output following methotrexate administration.

Main Results:

• A renal retention system for folic acid was identified, inhibitable by folic acid, 5-methyltetrahydrofolate, and, at higher concentrations, by methotrexate.
• This system involves a kidney-derived folate binder with similar affinities for folates and MTX.
• Methotrexate administration increased endogenous folate urinary output.
• A second, distinct renal retention system for methotrexate was observed, inhibitable only by unlabeled methotrexate, not folates, and not found in kidney extracts.

Conclusions:

• Two distinct systems mediate renal methotrexate retention in rats.
• One system involves shared folate binding, while the other is specific to methotrexate.
• These findings highlight the complex renal handling of methotrexate and its potential impact on endogenous folate levels.